A Dark Vector Cognition product

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

3K characters. Original on sec.gov · Markdown

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Information required by this Item is incorporated by reference from the discussion under the heading Stock Ownership in our 2022 Proxy Statement.

Equity Compensation Plan Information Table

The following table sets forth information about the grants of stock options, all share units and other rights under all of the Company’s equity compensation plans as of the close of business on December 31, 2021. The table does not include information about tax-qualified plans such as the West 401(k) Plan or the West Contract Manufacturing Savings and Retirement Plan.

Plan CategoryNumber of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (a)Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights (b)Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Columns (a)) (c)
Equity compensation plans approved by security holders2,559,296(1)$101.59(2)5,819,087(3)
Equity compensation plans not approved by security holders———
Total2,559,296101.595,819,087

(1) Includes 1,234,591 outstanding stock options, 11,138 stock appreciation rights, 165,793 performance share units, 22,507 restricted retention share units, and 140,049 deferred stock-equivalents units under the 2016 Plan. Includes 810,267 outstanding stock options, 9,916 stock appreciation rights, and 132,107 deferred stock-equivalents units under the 2011 Plan (which was terminated in 2016). Includes 35,593 deferred stock-equivalents under the 2007 Omnibus Incentive Compensation Plan (which was terminated in 2011). The average term of remaining options is 5.5 years. No future grants or awards may be made under the terminated plans. The total includes restricted performance share units at 100% of grant. The restricted performance share unit payouts were at 154.52%, 82.61%, and 49.39% in 2021, 2020 and 2019, respectively.

(2) All share units and deferred stock-equivalent units are excluded when determining the weighted-average exercise price of outstanding options.

(3) Represents 3,766,202 shares reserved under the Company’s Employee Stock Purchase Plan and 2,052,885 shares remaining available for issuance under the 2016 Plan. The estimated number of shares that could be issued for 2021 from the Employee Stock Purchase Plan is 126,360. This number of shares is calculated by multiplying the 65 shares per offering period per participant limit by 1,944, the number of current participants in the plan.

Previous: Item 11. EXECUTIVE COMPENSATION · Next: Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE